Tuesday, May 29, 2018

Boulder County veterinarians use alternatives in face of nationwide ...

The Denver Post-8 hours ago
Diane Matt, CEO of Colorado Veterinary Medical Association, said the group is aware of the shortage and people are worried that the drugs won't be available to ...

FDA Approves Semintra, Animal Drug for the Control of High Blood ...

Pet Age-May 25, 2018
The U.S. Food and Drug Administration has approved Semintra (telmisartan oral solution), the first FDA-approved animal drug to control systemic hypertension ..

Monday, April 30, 2018

Big pharmacy playas

dvm360-21 hours ago
In the world of online veterinary pharmacies, there are two kinds of companies out there—the interlopers up in your business (you know, like 1-800-PetMeds and the corner-store pharmacy chain that now sells vet drugs, WTH?) and then the two big players in your corner: Vetsource and Vets First Choice. So if your veterinary ...

Thursday, April 12, 2018

High Importance! Billions lost in growing illegal vet medicines market – report

Billions lost in growing illegal vet medicines market – report

vet times-1 hour ago
They also include compounded pharmaceuticals and illegal autogenous vaccines when these products are not manufactured or used appropriately, and according to regulations. The authors said continuing rapid growth ... A growing black market of drugs for pets, particularly in the EU and US. Illegal veterinary medicines ...

Tuesday, April 10, 2018

Medication Use in Horse Racing: Yea or Neigh?

Pharmacy Times-5 hours ago
Medication use in horse racing has become a hot topic across the country. Uniform standards have been established by the Racing Medication and Testing Consortium (RMTC) for the United States. However, not all states are following these guidelines.1,2 The National Uniform Medication Program consists of medication ...
04/02/2018Arrow Reliance IncCenter for Veterinary MedicineAdulterated Animal Food/MisbrandedNot Issued *

Tuesday, April 3, 2018

Beginning on May 23, 2018, the Center for Veterinary Medicine (CVM) will host a three-part webinar series to provide information on the new animal drug application approval process. CVM’s Office of New Animal Drug Evaluation (ONADE) is hosting this webinar series to address the FDA Electronic Submission Gateway (ESG) and CVM Electronic Submission System (ESS) registration processes as well as to provide information on how to use the eSubmitter tool.

Since the release of eSubmitter in March 2011, the number of electronic submissions has increased. The purpose of these webinars is to support the use of eSubmitter in the new animal drug application approval process as we move to 100% electronic submission on October 1, 2018, with the anticipated reauthorization of the Animal Drug User Fee Act (ADUFA) and Animal Generic Drug User Fee Act (AGDUFA). Each webinar listed below will be live-cast and recordings will be available on FDA.gov shortly after the presentation date.

Read entire article.

More Animal Health Topics

Monday, April 2, 2018

Eggleston Equine - Home | Facebook

22 hours ago - "You should only use a compounded drug by the order of a veterinarian and only in cases where an FDA approved drug does not exist or is deemed unusable for your ... Compounded Drugs for Horses - Get the facts. What is a drug? We commonly think all that's important is the active ingredient and how much is in the tablet ..

Friday, March 9, 2018

FDA Issues Guidance on Proprietary Names for New Animal Drugs

The U.S. Food and Drug Administration today issued draft guidance to provide recommendations to assist sponsors in developing proprietary names for new animal drugs in order to avoid contributing to medication errors, negatively impacting safe use of the drug, or misbranding the drug.

Draft Guidance for Industry #240, entitled "Proprietary Names for New Animal Drugs," proposes a framework for evaluating proposed proprietary names before submitting them for review by the FDA’s Center for Veterinary Medicine. The draft guidance also explains how new animal drug sponsors can request agency evaluation of a proposed proprietary name.

Read entire press release.